Ford Motor Co
Change company Symbol lookup
Select an option...
F Ford Motor Co
CPB Campbell Soup Co
T AT&T Inc
GSS Golden Star Resources Ltd
TBNK Territorial Bancorp Inc
YUM Yum! Brands Inc
RTX Raytheon Technologies Corp
NAKD Naked Brand Group Ltd
FAMI Farmmi Inc
PTPI Petros Pharmaceuticals Inc
Go

Consumer Discretionary : Automobiles | Large Cap Blend
Company profile

Ford Motor Company is an automobile company that designs, manufactures, markets, and services a full line of Ford trucks, utility vehicles, cars as well as Lincoln luxury vehicles. The Company operates in three segments: Automotive, Mobility and Ford Credit. The Automotive segment is engaged in developing, manufacturing, distributing, and servicing the vehicles, parts and accessories of Ford and Lincoln vehicles. The Mobility segment primarily includes the development of Ford’s autonomous vehicles and related businesses. The Company also holds ownership is Argo AI, which is a developer of autonomous driving systems, and Spin, which is a micro-mobility service provider. The Ford Credit segment is comprised of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. Ford Credit offers a wide variety of automotive financing products to and through automotive dealers throughout the world.

Closing Price
$19.14
Day's Change
-0.73 (-3.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
20.40
Day's Low
18.93
Volume
(Heavy Day)
Volume:
120,275,163

10-day average volume:
94,800,511
120,275,163

Marrone Bio Advances Novel Herbicides

9:05 am ET September 28, 2021 (Globe Newswire) Print

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, is advancing three novel bioherbicides in its research and development pipeline, further strengthening its position as a leading provider of sustainable agricultural solutions. These biologically based herbicides are a key component of the company's strategic growth plan, and provide entry into the $27 billion weed control market.

"There is an urgent need for new, more sustainable alternatives given the vast number of herbicides with known cases of weed resistance and the lack of new modes of action," Chief Executive Officer Kevin Helash said. "We believe our research can bring new options to our customers that will enhance performance and profitability, and provide a more environmentally responsible option for both conventional and organic farmers."

Marrone Bio has three proprietary bioherbicides in its R&D portfolio. The first two, MBI-005 and MBI-011, have prior regulatory approval from the U.S. Environmental Protection Agency, and now are undergoing further formulation refinement. The third, MBI-014/015, has progressed to advanced stages of development. Current results indicate that MBI-014/015 has herbicidal properties estimated to be 50-to-100 times more active than leading chemical alternatives.

The MBI family of bioherbicides can control the most economically significant and resistant weeds, including annual broadleaves, grasses and sedges in major row crops as well as vegetable and turf markets. The products can be used at various points in the growing season to give farmers maximum flexibility to control weeds before, during and after planting.

From the more than 12,000 microbes screened, the company's R&D team has discovered approximately 500 herbicidal microbes that can be advanced through genomics, bioinformatics and synthetic biology systems. This broad library of microbes can potentially lead to the discovery of additional novel active ingredients and new modes of action.

"These advancements further solidify our leadership position as the supplier of choice for farmers striving to meet the increasing demand for more responsibly grown food and fiber. Our family of bioherbicides exemplifies how we are aggressively advancing our pipeline to provide a meaningful return on investment to growers and investors alike," said Chief Executive Officer Kevin Helash.

An overview of the company's R&D program, including information on its herbicides, is available in a presentation on the MBI web site at www.investors.marronebio.com.

Source: IHS Markit, Agrochemical Market Analysis, Industry Overview: 2020 Market

About Marrone Bio Innovations

Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. Our portfolio of 18 products helps customers operate more sustainably while increasing their return on investment. The company's commercial products are sold globally and supported by a robust portfolio of more than 500 issued and pending patents. Our end markets include row crops; fruits and vegetables; trees, nuts and vines; and greenhouse production. Marrone Bio's research and development program uses proprietary technologies to isolate and screen naturally occurring microorganisms and plant extracts to create new, environmentally sound solutions in agriculture.

Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: Twitter, LinkedIn and Instagram.

Marrone Bio Innovations Forward Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing the company's views as of any subsequent date. Examples of such statements include financial guidance and other statements regarding the company's future revenue growth, margins, operating expenses, and other financial results; adoption of the company's products; and the potential benefits and value of the company's products. Such forward-looking statements are based on information available to the company as of the date of this release and involve a number of risks and uncertainties, some beyond the company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including the recent uncertainty in the global economy and industry-specific economy caused by the COVID-19 pandemic, consumer, regulatory and other factors affecting demand for the company's products, any difficulty in expanding the company's sales and marketing infrastructure or marketing the company's products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, adverse actions by distributors, manufacturers, regulatory agencies and other relevant third parties and costs associated with any strategic acquisitions or other business opportunities we elect to pursue. Additional information that could lead to material changes in the company's performance is contained in its filings with the Securities and Exchange Commission. The company is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Marrone Bio Innovations Contact:

Clyde Montevirgen

Vice President of Business Development & Investor Relations

Telephone: 530-750-2800

info@marronebio.com

https://ml.globenewswire.com/media/58629bff-cc50-447e-b84b-fd9a31125411/small/logo-mbi-web-png.png

https://ml.globenewswire.com/media/58629bff-cc50-447e-b84b-fd9a31125411/small/logo-mbi-web-png.png

comtex tracking

COMTEX_394167255/2010/2021-09-28T09:05:33

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.